CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Mar. 31, 2019	Dec. 31, 2018
Assets
Cash and cash equivalents	[1]	$ 1,937	$ 1,139	[2]
Short-term investments	[1]	9,682	17,694
Trade accounts receivable, less allowance for doubtful accounts: 2019—$538; 2018—$541	[1]	9,599	8,025
Inventories	[1],[3]	8,029	7,508
Current tax assets	[1]	3,598	3,374
Other current assets	[1]	2,567	2,461
Assets held for sale	[1]	9,877	9,725
Total current assets	[1]	45,290	49,926
Long-term investments	[1]	2,859	2,767
Property, plant and equipment, less accumulated depreciation: 2019—$16,158; 2018—$16,591	[1]	13,467	13,385
Identifiable intangible assets, less accumulated amortization	[1],[4]	34,039	35,211
Goodwill	[1]	53,487	53,411
Noncurrent deferred tax assets and other noncurrent tax assets	[1]	1,946	1,924
Other noncurrent assets	[1]	4,333	2,799
Total assets	[1]	155,421	159,422
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2019—$4,471; 2018—$4,776	[1]	9,410	8,831
Trade accounts payable	[1]	4,156	4,674
Dividends payable	[1]	0	2,047
Income taxes payable	[1]	1,849	1,265
Accrued compensation and related items	[1]	1,797	2,397
Other current liabilities	[1]	10,276	10,753
Liabilities held for sale	[1]	1,935	1,890
Total current liabilities	[1]	29,423	31,858
Long-term debt	[1]	35,733	32,909
Pension benefit obligations, net	[1]	5,125	5,272
Postretirement benefit obligations, net	[1]	1,332	1,338
Noncurrent deferred tax liabilities	[1]	3,591	3,700
Other taxes payable	[1]	14,712	14,737
Other noncurrent liabilities	[1]	6,346	5,850
Total liabilities	[1]	96,263	95,664
Commitments and Contingencies	[1]
Preferred stock	[1]	19	19
Common stock	[1]	468	467
Additional paid-in capital	[1]	86,635	86,253
Treasury stock	[1]	(110,781)	(101,610)
Retained earnings	[1]	93,388	89,554
Accumulated other comprehensive loss	[1]	(10,923)	(11,275)
Total Pfizer Inc. shareholders’ equity	[1]	58,806	63,407
Equity attributable to noncontrolling interests	[1]	352	351
Total equity	[1],[5]	59,158	63,758
Total liabilities and equity	[1]	$ 155,421	$ 159,422

[1] Amounts may not add due to rounding.

[2] Amounts may not add due to rounding.

[3] The change from December 31, 2018 reflects increases for certain products to meet targeted levels in the normal course of business, including inventory build for supply recovery and market demand.

[4] The decrease in Identifiable intangible assets, less accumulated amortization, is primarily due to amortization and intangible asset impairment charges, partially offset by additions for the period. See Note 4 for additional information on intangible asset impairments.

[5] Amounts may not add due to rounding.